MedTech Featured Stories

Bristol subpoenaed over foreign sales practices

4/26/2012

U.S. drugmaker Bristol-Myers Squibb Co said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries.

Bristol-Myers, in a filing, said it received the subpoena from the U.S. Securities and Exchange Commission (SEC) last month in connection with an investigation under the Foreign Corrupt Practices Act (FCPA).
 

Reuters



Return to Previous Page

Today Is:
Saturday, August 30, 2014


August Events

<< >>
SMTWTFS
12
3456789
10111213141516
17181920212223
24252627282930
31